Win ratio aligns with and enhances interpretation of REPRIEVE's primary findings.
Publication
, Journal Article
Davies Smith, E; Douglas, PS; McCallum, S; Troendle, J; Diggs, MR; Lu, AB; Chu, SM; Umbleja, T; Lu, MT; Zanni, MV; Grinspoon, SK; Ribaudo, HJ
Published in: Clin Infect Dis
September 1, 2025
We performed a win ratio (WR) analysis of REPRIEVE, a randomized trial of pitavastatin vs placebo for CVD in people with HIV, to assess robustness to event severity. WR aligns with primary findings, and provides insight into pitavastatin protections: persistent advantage over placebo on CV Death, Stroke, and Myocardial Infarction.
Duke Scholars
Published In
Clin Infect Dis
DOI
EISSN
1537-6591
Publication Date
September 1, 2025
Location
United States
Related Subject Headings
- Microbiology
- 3202 Clinical sciences
- 11 Medical and Health Sciences
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Davies Smith, E., Douglas, P. S., McCallum, S., Troendle, J., Diggs, M. R., Lu, A. B., … Ribaudo, H. J. (2025). Win ratio aligns with and enhances interpretation of REPRIEVE's primary findings. Clin Infect Dis. https://doi.org/10.1093/cid/ciaf477
Davies Smith, Emma, Pamela S. Douglas, Sara McCallum, James Troendle, Marissa R. Diggs, Alex B. Lu, Sarah M. Chu, et al. “Win ratio aligns with and enhances interpretation of REPRIEVE's primary findings.” Clin Infect Dis, September 1, 2025. https://doi.org/10.1093/cid/ciaf477.
Davies Smith E, Douglas PS, McCallum S, Troendle J, Diggs MR, Lu AB, et al. Win ratio aligns with and enhances interpretation of REPRIEVE's primary findings. Clin Infect Dis. 2025 Sep 1;
Davies Smith, Emma, et al. “Win ratio aligns with and enhances interpretation of REPRIEVE's primary findings.” Clin Infect Dis, Sept. 2025. Pubmed, doi:10.1093/cid/ciaf477.
Davies Smith E, Douglas PS, McCallum S, Troendle J, Diggs MR, Lu AB, Chu SM, Umbleja T, Lu MT, Zanni MV, Grinspoon SK, Ribaudo HJ. Win ratio aligns with and enhances interpretation of REPRIEVE's primary findings. Clin Infect Dis. 2025 Sep 1;
Published In
Clin Infect Dis
DOI
EISSN
1537-6591
Publication Date
September 1, 2025
Location
United States
Related Subject Headings
- Microbiology
- 3202 Clinical sciences
- 11 Medical and Health Sciences
- 06 Biological Sciences